MLLT1 and leukemia: For example, XL-13m is a selective inhibitor of the YEATS (YAF9, ENL, AF9, TAF14, SAS5) domain of ENL (Eleven Nineteen Leukemia), which can disrupt chromatin binding of ENL in vivo.